VRCA compared with SNDL: revenue, margins and what each company keeps, and the suppliers and customers both name

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

SNDLSndl Inc.

Mkt capRevenueRevenue

Compare

VRCAVerrica Pharmaceuticals Inc.

SNDLSndl Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VRCA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−5.22%—

SNDL1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 27 '26±20.1%▲+2.36%×0.12

= impliedVRCA realized, solidSNDL realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedSource: market data

VRCAVerrica Pharmaceuticals Inc.

3.35▲+8.33%· post 3.35

Mkt cap$54.8MRevenue$6MQ2 FY26Revenue$36MFY25

SNDLSndl Inc.

1.42▲+2.54%· post 1.41

ClosedNov 6 '26

Mkt cap$372.7MRevenue—Revenue—

Compare

ClosedNov 6 '26

VRCAVerrica Pharmaceuticals Inc.

SNDLSndl Inc.

3.35▲+8.33%post 3.35

Price

1.42▲+2.54%post 1.41

$54.8M

Mkt cap

$372.7M

Q2 FY26$6M

Revenue

—

FY25$36M

Revenue

—

VRCA3.35▲+8.33%vsSNDL1.42▲+2.54%ClosedNov 6 '26